Summary
Sun Pharma reported a 27% year-on-year increase in Q1 net profit to ₹2,895 crore, with revenue climbing 10.5% to ₹15,300 crore. This growth was driven by strong performance in India and its innovative medicines business, despite weaker US formulations sales.